CORI News
Archived Headlines
- Corium International prices IPO at $8, below the range 04/03/14
- 8 US IPOs planned for the week of Mar 31 03/31/14
- Drug delivery systems provider Corium International sets terms for $61 million IPO 03/24/14
- Contraceptive patch biotech Agile Therapeutics files for a $69 million IPO 03/17/14
- US IPO Recap: Coupons.com jumps 88% and Biomet files for an IPO 03/10/14
See more
Bone biotech PolyPid files for a $24 million IPO
PolyPid, an early stage drug delivery biotech developing an antibiotic coating for bone repair, filed on Tuesday with the SEC to raise up to $24 million in an initial public offering. PolyPid's two lead candidates, BonyPid-1000 and BonyPid-500, combat...read more
Adhesive patch biotech Zosano Pharma sets terms for $70 million IPO
Zosano Pharma, a biotech developing a transdermal delivery system to treat osteoporosis, announced terms for its IPO on Wednesday. The Fremont, CA-based company plans to raise $70 million by offering 6.4 million shares at a price range of $10 to $12. At the...read more
Adhesive patch biotech Zosano Pharma files for a $65 million IPO
Zosano Pharma, a biotech developing a transdermal delivery system to treat osteoporosis, filed on Tuesday with the SEC to raise up to $65 million in an initial public offering. The Fremont, CA-based company, which was spun out of Johnson & Johnson (JNJ) in...read more
Contraceptive patch biotech Agile Therapeutics sets terms for $60 million IPO
Agile Therapeutics, a biotech developing prescription adhesive contraceptives, announced terms for its IPO on Friday. The Princeton, NJ-based company plans to raise $60 million by offering 4.6 million shares at a price range of $12 to $14. At the midpoint of the...read more